AU5576498A - Prophylactic or therapeutic agent for diabetic complication - Google Patents

Prophylactic or therapeutic agent for diabetic complication

Info

Publication number
AU5576498A
AU5576498A AU55764/98A AU5576498A AU5576498A AU 5576498 A AU5576498 A AU 5576498A AU 55764/98 A AU55764/98 A AU 55764/98A AU 5576498 A AU5576498 A AU 5576498A AU 5576498 A AU5576498 A AU 5576498A
Authority
AU
Australia
Prior art keywords
prophylactic
therapeutic agent
diabetic complication
complication
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55764/98A
Other languages
English (en)
Inventor
Hiroyuki Koike
Toshio Sada
Hiroaki Yanagisawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU5576498A publication Critical patent/AU5576498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55764/98A 1997-02-05 1998-01-23 Prophylactic or therapeutic agent for diabetic complication Abandoned AU5576498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2257697 1997-02-05
JP9-22576 1997-02-05
JP9-57244 1997-03-12
JP5724497 1997-03-12
PCT/JP1998/000256 WO1998034922A1 (fr) 1997-02-05 1998-01-23 Agent destine a la prophylaxie ou la therapie des complications diabetiques

Publications (1)

Publication Number Publication Date
AU5576498A true AU5576498A (en) 1998-08-26

Family

ID=26359819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55764/98A Abandoned AU5576498A (en) 1997-02-05 1998-01-23 Prophylactic or therapeutic agent for diabetic complication

Country Status (2)

Country Link
AU (1) AU5576498A (fr)
WO (1) WO1998034922A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
DK3144306T3 (en) * 2014-05-13 2018-01-02 Teijin Pharma Ltd pyrazine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
JP3810020B2 (ja) * 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
JPH09323991A (ja) * 1996-06-04 1997-12-16 Kotobuki Seiyaku Kk 新規カルボキシメチリデンシクロヘプトイミダゾール誘導体及びその製造方法並びにこれを含有する薬剤

Also Published As

Publication number Publication date
WO1998034922A1 (fr) 1998-08-13

Similar Documents

Publication Publication Date Title
AU2263197A (en) Diabetes therapy
AU5760900A (en) Multiple agent diabetes therapy
AU5497098A (en) Remedies for diabetes
AU7217698A (en) Fracture reduction device
AUPO203996A0 (en) Therapeutic uses
AUPO665397A0 (en) Novel therapy for constipation
AU5536498A (en) Dual earplug
AU7226998A (en) Safety syringe
AU1673297A (en) Therapeutic agent for diabetes
AU3701397A (en) Anti-herpesviral agent
AU6006898A (en) Skin preparation
AU6715098A (en) Vascular remodeling agent
AU6220798A (en) Release agent
AU6582098A (en) Medical splint product
AU5944898A (en) Catheter
AUPO565997A0 (en) Propanolamine derivatives
AU9566698A (en) Firefighter goggle
AU1171099A (en) Therapeutic agents
AU5490298A (en) Syringe
AU5576498A (en) Prophylactic or therapeutic agent for diabetic complication
AU1645599A (en) Human matrilin-3
AU7641098A (en) Therapeutic composition
AU2440599A (en) Therapeutic agent for complication of diabetes
AU6092798A (en) Condom
AU2699397A (en) Catheter application strap